skip to Main Content

“Chronic disease mobile health apps need better value propositions and evidence.”
Emily Belowich
Emily Belowich
Senior Associate
0
Cell and gene therapy clinical trials underway worldwide
“A higher proportion of dually eligible ESRD patients could enroll in MA.”
Joanna Young
Joanna Young
Principal
0%
Potential OOP drug cost for Part D MS beneficiaries
Back To Top